Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Faartoft Jensen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Haematology|December 5, 2024
The Prevalence of Diffuse Large B-Cell Lymphoma Varies Substantially by Methods Applied: Results From a Population-Based StudyMikkel Runason Simonsen, Jonas Faartoft Jensen, Thomas Stauffer Larsen, et al.
BMC Medical Research Methodology|May 26, 2025
Development of time to event prediction models using federated learningRasmus Rask Kragh Jørgensen, Jonas Faartoft Jensen, Tarec El-Galaly, et al.
Cancers|May 14, 2025
Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort StudyEva Futtrup Maksten, Jonas Faartoft Jensen, Gitte Thomsen, et al.
International Journal of Hygiene and Environmental Health|January 21, 2025
PFAS concentrations in the blood of Danish surfersMette Hyllegaard Madsen, Janne Julie Møller, Niels Erik Ebbehøj, et al.
European Journal of Epidemiology|January 3, 2025
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register studyMaren Poulsgaard Jørgensen, Andreas Kiesbye Øvlisen, Jonas Faartoft Jensen, et al.
The Lancet Regional Health. Europe|January 23, 2025
Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort studyNanna Nørtoft Nielsen, Jonas Faartoft Jensen, Joachim Baech, et al.
British Journal of Haematology|July 22, 2025
Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort studyRikke Hedegaard Jensen, Christian Teglgaard, Jonas Faartoft Jensen, et al.
British Journal of Haematology|April 17, 2026
Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classificationLisa-Maj Christensen, Mikkel Runason Simonsen, Jonas Faartoft Jensen, et al.
Ejhaem|January 27, 2025
The long-term risk of immune-related conditions in survivors of diffuse large B-cell lymphoma: A Danish nationwide registry studyLaura Schou Pedersen, Nadja Nørholm Klausen, Jonas Faartoft Jensen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Haematology|December 5, 2024
The Prevalence of Diffuse Large B-Cell Lymphoma Varies Substantially by Methods Applied: Results From a Population-Based StudyMikkel Runason Simonsen, Jonas Faartoft Jensen, Thomas Stauffer Larsen, et al.
BMC Medical Research Methodology|May 26, 2025
Development of time to event prediction models using federated learningRasmus Rask Kragh Jørgensen, Jonas Faartoft Jensen, Tarec El-Galaly, et al.
Cancers|May 14, 2025
Work Ability in Patients with Chronic Myeloid Leukemia: A Danish Nationwide Cohort StudyEva Futtrup Maksten, Jonas Faartoft Jensen, Gitte Thomsen, et al.
International Journal of Hygiene and Environmental Health|January 21, 2025
PFAS concentrations in the blood of Danish surfersMette Hyllegaard Madsen, Janne Julie Møller, Niels Erik Ebbehøj, et al.
European Journal of Epidemiology|January 3, 2025
Prevalence and incidence of mastocytosis in adults: a Danish nationwide register studyMaren Poulsgaard Jørgensen, Andreas Kiesbye Øvlisen, Jonas Faartoft Jensen, et al.
The Lancet Regional Health. Europe|January 23, 2025
Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort studyNanna Nørtoft Nielsen, Jonas Faartoft Jensen, Joachim Baech, et al.
British Journal of Haematology|July 22, 2025
Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort studyRikke Hedegaard Jensen, Christian Teglgaard, Jonas Faartoft Jensen, et al.
British Journal of Haematology|April 17, 2026
Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classificationLisa-Maj Christensen, Mikkel Runason Simonsen, Jonas Faartoft Jensen, et al.
Ejhaem|January 27, 2025
The long-term risk of immune-related conditions in survivors of diffuse large B-cell lymphoma: A Danish nationwide registry studyLaura Schou Pedersen, Nadja Nørholm Klausen, Jonas Faartoft Jensen, et al.
Pageof 1